A positive feedback loop that regulates cyclooxygenase-2 expression and prostaglandin F2alpha synthesis via the F-series-prostanoid receptor and extracellular signal-regulated kinase 1/2 signaling pathway.
about
Crystal Structures of Three Classes of Non-Steroidal Anti-Inflammatory Drugs in Complex with Aldo-Keto Reductase 1C3Novel suppression mechanism operating in early phase of adipogenesis by positive feedback loop for enhancement of cyclooxygenase-2 expression through prostaglandin F2α receptor mediated activation of MEK/ERK-CREB cascadeOverexpression of AKR1C3 significantly enhances human prostate cancer cells resistance to radiationExpression of oestrogen receptors, ERalpha, ERbeta, and ERbeta variants, in endometrial cancers and evidence that prostaglandin F may play a role in regulating expression of ERalpha.Interleukin-11 in endometrial adenocarcinoma is regulated by prostaglandin F2alpha-F-prostanoid receptor interaction via the calcium-calcineurin-nuclear factor of activated T cells pathway and negatively regulated by the regulator of calcineurin-1.PGF2α-F-prostanoid receptor signalling via ADAMTS1 modulates epithelial cell invasion and endothelial cell function in endometrial cancer.Cyclooxygenases and lipoxygenases in cancer.Synergistic suppression of early phase of adipogenesis by microsomal PGE synthase-1 (PTGES1)-produced PGE2 and aldo-keto reductase 1B3-produced PGF2α.Trypanosoma cruzi infection and endothelin-1 cooperatively activate pathogenic inflammatory pathways in cardiomyocytes.Inhibitors of type 5 17β-hydroxysteroid dehydrogenase (AKR1C3): overview and structural insights.The ω6-fatty acid, arachidonic acid, regulates the conversion of white to brite adipocyte through a prostaglandin/calcium mediated pathway.The Prostaglandin F Synthase Activity of the Human Aldose Reductase AKR1B1 Brings New Lenses to Look at Pathologic Conditions.Adenovirus type 5 E1A-induced apoptosis in COX-2-overexpressing breast cancer cells.What are cyclooxygenases and lipoxygenases doing in the driver's seat of carcinogenesis?Anandamide-derived prostamide F2α negatively regulates adipogenesisF-prostanoid receptor alters adhesion, morphology and migration of endometrial adenocarcinoma cellsSeminal plasma and prostaglandin E2 up-regulate fibroblast growth factor 2 expression in endometrial adenocarcinoma cells via E-series prostanoid-2 receptor-mediated transactivation of the epidermal growth factor receptor and extracellular signal-reProstaglandin E2 and F2alpha activate the FP receptor and up-regulate cyclooxygenase-2 expression via the cyclic AMP response element.Prostaglandin F2alpha-F-prostanoid receptor signaling promotes neutrophil chemotaxis via chemokine (C-X-C motif) ligand 1 in endometrial adenocarcinomaCREB mediates prostaglandin F2alpha-induced MUC5AC overexpression.Prostanoids receptors signaling in different diseases/cancers progression.Molecular mechanisms of renal cellular nephrotoxicity due to radiocontrast mediaDifferential gene expression in the bovine corpus luteum during transition from early phase to midphase and its potential role in acquisition of luteolytic sensitivity to prostaglandin F2 alpha.The F-prostaglandin receptor is a novel marker for tumor endothelial cells in renal cell carcinoma.Acute Changes in the Concentrations of Prostaglandin F2α (PGF) and Cortisol in Uterine and Ovarian Venous Blood During PGF-induced Luteolysis in Cows
P2860
Q27671816-FCD5FD99-53AD-4AED-8EF5-9140BE2BFE8CQ28586698-E119E620-30BA-4F66-929A-65EE37641FC6Q28817905-1503C912-8177-4345-9D70-F34400C9EB7EQ33503908-825D4F6F-E7DE-4E43-BACA-00A6728EA26AQ33556402-3ECFA0AA-D87F-4FC8-BC0A-617652105FF8Q33692377-982C82DF-777A-4041-865A-3795AFFCA823Q34224752-A4BB3E3A-7385-40A2-B2BC-4AA2FEB6E3D3Q34412709-A3EE8A79-A86C-478D-82A0-BEF13E4983A8Q34587039-C01E4234-EBF3-457B-AC0F-547D3CB6D4A7Q34618859-772B29A1-9A25-4820-A297-B0C3A9A043B3Q34684310-E6413494-2873-40A1-9775-C72AB5D53033Q35988382-47DFFF88-0A1F-4102-B6C5-5DDE0FAA698EQ36393246-886E2E0B-3086-4F0E-B6E0-FA865F4F5DECQ36572139-DD1B4E86-6284-4879-B80E-B3911A4A6432Q37095444-C17E0889-D7A8-4E88-8C03-F93AAA73BFCEQ37223970-2D25ED6E-C99E-4ED2-B7D4-C33BB44A423BQ37223974-B00397BC-85A3-491F-86E0-A30290514A33Q37223979-5B671429-936C-46FA-8234-3548198C01FFQ37266333-911B5AD1-21D4-4297-8FAA-F7CA8804DF34Q37373688-FE98B9EA-D48E-4843-B631-9052FFEB867CQ38074716-0B666607-6ECA-46C6-8CC6-A315CEE3E534Q38205449-E61C67A4-3759-4F04-BFF8-3AC460AF5473Q38357176-2BFFC2F7-14A8-4F63-8F49-ACEF0903F37FQ39203504-6E33D9CF-AFAC-4843-9960-91EBE758DD23Q57716974-5521AA49-E3E3-404F-A1DE-773E602A7F6F
P2860
A positive feedback loop that regulates cyclooxygenase-2 expression and prostaglandin F2alpha synthesis via the F-series-prostanoid receptor and extracellular signal-regulated kinase 1/2 signaling pathway.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
A positive feedback loop that ...... kinase 1/2 signaling pathway.
@en
type
label
A positive feedback loop that ...... kinase 1/2 signaling pathway.
@en
prefLabel
A positive feedback loop that ...... kinase 1/2 signaling pathway.
@en
P50
P356
P1433
P1476
A positive feedback loop that ...... d kinase 1/2 signaling pathway
@en
P2093
Henry N Jabbour
Sheila C Boddy
P304
P356
10.1210/EN.2005-0804
P407
P577
2005-08-04T00:00:00Z